Lorazepam Tapering Protocol
For safe discontinuation of lorazepam, implement a gradual taper with 10% reduction of the most recent dose every 2-4 weeks, with slower tapers (10% per month) for long-term users to minimize withdrawal symptoms. 1
Initial Assessment and Preparation
- Evaluate the patient's duration of lorazepam use, as longer-term users (≥1 year) require slower tapers 2
- Obtain patient agreement and involvement in the tapering plan to improve success rates 1, 2
- Set realistic expectations about the tapering process and potential withdrawal symptoms 1
Recommended Tapering Schedule
- For standard cases: Reduce dose by 10% of the most recent dose every 2-4 weeks 1, 2
- For long-term users: Consider slower reductions of 10% per month or less 1, 2
- Example for 2mg daily dose:
Monitoring During Taper
- Monitor for withdrawal symptoms after each dose reduction before proceeding to the next step 1
- Common withdrawal symptoms include:
Managing Withdrawal Symptoms
- If withdrawal symptoms become severe, return to the previous well-tolerated dose and slow the taper further 1
- Consider adjunctive medications for specific withdrawal symptoms:
Special Considerations
- Final doses before complete cessation may need to be very small (as low as 0.25mg or less) to prevent a large decrease in receptor activity when stopped 5, 6
- For patients with a history of seizures, implement even slower tapering 2
- If the patient is also taking opioids, consider tapering the benzodiazepine first 2
- Never abruptly discontinue lorazepam except in cases of confirmed diversion or serious medical toxicity 1
Follow-up and Support
- Monitor patients at least monthly during the tapering process 2
- Incorporate non-pharmacological approaches:
- Never abandon patients who are struggling with the taper; consider pausing rather than discontinuing care 1
Common Pitfalls to Avoid
- Tapering too quickly (less than 10% reduction every 2-4 weeks) 1, 4
- Setting arbitrary time limits for completing the taper 1
- Failing to recognize that withdrawal symptoms may be mistaken for recurrence of the original condition 5
- Underestimating the potential for rebound insomnia, which can be several times worse than baseline sleep disturbance 3